Congress
White House, hemp lobbyists bet on shutdown politics to delay ‘diet weed’ ban
President Donald Trump and hemp industry lobbyists are hoping to win a final vote on Capitol Hill next week to skirt a ban on intoxicating products — with shutdown politics as leverage.
Nine months ago, Congress cleared a bill to close a loophole created in 2018 that allowed the sale of some hemp-derived products containing types of THC colloquially known as “diet weed.” That ban is supposed to take effect in mid-November, or roughly 11 weeks, to limit overall THC levels in hemp products that can get people high — including gummies, canned drinks, pills and vapes.
But Trump and industry leaders successfully lobbied Senate leaders to add language to a government funding patch earlier this month to delay the ban until mid-December, with the administration promising instead to finalize regulations cracking down on how the products are made and sold.
Now House Republican leaders are aiming to clear that bill for Trump’s signature early next week, according to three people granted anonymity to disclose private discussions. And many GOP lawmakers are not pleased at the prospect of being rolled.
Rep. Riley Moore (R-W.Va.) told reporters last week that he expected House lawmakers would “iron out” some “sticking points” with the Senate-passed funding bill, “particularly the hemp issue,” rather than pass the legislation without changes — which appears to be GOP leadership’s current plan.
Sen. Ted Budd (R-N.C.) was more blunt: “it is morally reprehensible to threaten a shutdown over a loophole Congress agreed to close to less than a year ago,” he said in a statement Thursday.
Yet despite fierce pushback from lawmakers warning that the intoxicating products are harming Americans, hemp industry leaders are preparing for a victory, betting members of Congress ultimately care more about swiftly passing legislation to avert a Sept. 30 government shutdown before the midterms.
“Any effort to try to shut down the government — over a one-month delay on a hemp issue — I don’t think is going to fly well with most members of Congress,” Jonathan Miller, a top lawyer for the U.S. Hemp Roundtable advocacy group, said in an interview this week.
The White House did not respond to a request for comment about its plans for imposing new rules on hemp products in the coming months. But the Trump administration is expected to need more time than mid-December to finalize regulations, so hemp industry representatives are discussing a “regulatory bridge” that would impose temporary rules while continuing to avoid a full ban, according to Miller.
That could include restricting purchase to adults age 21 and older, blocking imports from China, mandating certain manufacturing practices, cracking down on copycat products that look like popular candy or potato chips and requiring transparency in product labeling.
While lawmakers have been back home over their summer break, hemp industry leaders have fanned out across the country to make their case for this plan. “The hemp industry does not have an August recess,” Christopher Lackner, head of the Hemp Beverage Alliance, said in an interview this month of the group’s work to facilitate passage of the Senate-passed funding bill.
Trump administration officials have also been telling reluctant lawmakers they will use the one-month delay to work on regulations. “The White House has committed to me that they’re committed to regulate the industry,” Sen. Rick Scott (R-Fla.) said in an interview this month.
Sen. Pete Ricketts (R-Neb.), who fought in the Senate to retain the ban as originally intended, said White House officials have said “they don’t want another extension, and I agree with that.”
In a statement, Ricketts said that “manufactured high-THC products like gummies and drinks are putting our kids in the hospital” and need to be taken “off our shelves.”
Some supporters of the ban say the White House and industry are just employing delay tactics to get to December, when lawmakers will face another pressure campaign to delay the ban while they are motivated to avert a shutdown before leaving town for the holidays.
“What they’re really after is to try to jam this on some must-pass, end-of-the-year funding,” Budd told reporters earlier this month. “That’s really what this is about.”
Budd fought to block the delay in the Senate as part of the government funding measure, but his amendment to that end was shot down 61-32 before the chamberpassed the legislation, sending it on for House action.
Trump personally called Budd after the senator filed the amendment and talked about creating federal regulations for hemp products, according to a Senate aide granted anonymity to describe the private discussion.
Days later, Budd demanded a vote on the amendment anyway and continues to slam the hemp industry.
“It is clear that businesses that sell unregulated, intoxicating products will stop at nothing to protect their bottom line, even at the expense of children’s health and safety,” he said in a statement this week.
Besides lawmakers fighting to ban intoxicating hemp products, others are pushing alongside the White House and industry for federal regulations.
Rep. Morgan Griffith (R-W.Va.) has crafted legislation that would direct the Food and Drug Administration to create federal rules for intoxicating hemp products and wants to see mandates for third-party testing, as well as new THC limits per serving.
Griffith told reporters Thursday the “deadline push” in the Senate-passed government funding measure “is not long enough” to finalize necessary regulations.
Since state limits for THC vary widely throughout the country and the federal government has taken years to step in since the hemp loophole was created in 2018, Griffith argued it makes more sense to regulate the intoxicating products than to enact a federal ban.
“That horse is out of the barn,” he said. “What we need to do is corral it.”
Kelsey Brugger, Amanda Friedman and Rachel Shin contributed to this report.
Sen. Ron Johnson is sending a letter Monday requesting a conference meeting to discuss the midterm results and a delay in the leadership election.
Johnson has gathered enough signatures to force the meeting under the Senate GOP’s rules and is proposing the gathering for 9 a.m. Tuesday.
“Tuesday’s result was a stunning defeat,” Johnson and his backers write in the letter to Conference Chair Tom Cotton (R-Ark.), a copy of which was obtained by POLITICO. “Holding leadership elections without engaging in a robust discussion and evaluation of how those running for leadership intend to lead would be political malpractice”
Republicans still expect their leadership election to be held Tuesday, where Majority Leader John Thune is so far unopposed to lead the party next year in the minority.
Sen. Chris Murphy announced Friday that he has been released from the hospital after suffering a stroke last week, but will miss “several weeks” of Senate votes while he continues to recover.
“The doctors are very encouraged by the progress I’ve made so far,” the Connecticut Democrat said in a statement. “In order to take my recovery seriously and get back to work on the quickest timeline possible, I will be spending several weeks at a rehabilitation center after being discharged from the hospital today.”
He added that he remains in touch remotely with his staff and colleagues.
Murphy, who was hospitalized last weekend, said Friday that he was “diagnosed with a small bleed in the thalamus region of my brain.” Jose Suarez, the Chief of Neurosciences Critical Care at The Johns Hopkins Hospital, said in a separate statement released by Murphy’s office that the senator “experienced a small hemorrhagic stroke.”
“He has shown tremendous progress, and at the current rate of improvement, we expect that he will make a full recovery following rehabilitation,” Suarez added.
Murphy is the latest senator to suffer a stroke in recent years. Sens. Chris Van Hollen (D-Md.) and Ben Ray Lujan (D-N.M.) were both hospitalized for strokes in 2022. Sen. John Fetterman (D-Pa.), at that time a Senate candidate, also had a stroke in 2022 that he later described as near fatal.
The head of the Congressional Progressive Caucus said his group will still be power brokers in a massive Democratic majority in a strategy memo previewing plans for next term.
“While some in the press have speculated that a majority of this size undermines our influence within the caucus, they have it exactly backwards,” Rep. Greg Casar of Texas said in the Friday memo obtained by Blue Light News. “Big majorities are good for getting big things done. Our goal is not to win a battle against other Democratic caucuses. It is to pass longstanding progressive priorities that bring down costs, root out corruption, and boost wages.”
The CPC will have at least 105 members next term, according to the memo. If Democrats had a narrow majority, progressives — and any other faction in the caucus — could have used their votes as leverage. Now that presumptive speaker Hakeem Jeffries will have as many 30 votes to spare, Democrats broadly are recalibrating their approach next term.
Casar laid out a “three-pronged” strategy for the CPC to “wield our power” in the three-page memo — tackling legislation, oversight and “holding Donald Trump to his word on populist economic policies.”
“Small majorities give corporate special interest groups the ability to block popular populist policies by recruiting a small number of opponents; a big majority gives us the advantage,” he said.
Casar previewed how the CPC can engage with Trump, noting that “one of the few bright spots for bipartisan lawmaking” was a housing bill that banned private equity firms from buying homes. He noted the caucus should push Trump to cap credit card interest rates, lower credit card fees for small businesses and lower prescription drug costs.
“While we oppose [Trump] strongly on the vast majority of fronts, we should send bills to his desk that would lower prices and raise paychecks. If he signs them, good. If he vetoes those bills, that will propel us to a continued Democratic majority and a trifecta where a Democratic president can sign these proposals into law,” he said.
Casar also outlined oversight targets beyond the administration, urging Democrats to specifically investigate corporations that use customer data for “surveillance pricing,” health care companies that are “taking advantage of seniors” through the Medicare Advantage program and artificial intelligence labs who are “putting jobs and lives at risk.”
“By focusing not just on the Trump administration but also on big corporations and billionaires, we will show the American people we are not just anti-Trump but also pro-worker and pro-consumer,” he said.
-
Politics1 year agoJohn Legend advises Trump to drop the ‘dictator s‑‑‑’ if he wants Nobel Peace Prize
-
Politics2 years agoFormer ‘Squad’ members launching ‘Bowman and Bush’ YouTube show
-
Uncategorized2 years ago
Bob Good to step down as Freedom Caucus chair this week
-
The Josh Fourrier Show2 years agoDOOMSDAY: Trump won, now what?
-
The Dictatorship2 years agoPete Hegseth’s tenure at the Pentagon goes from bad to worse
-
Politics2 years agoFormer Kentucky AG Daniel Cameron launches Senate bid
-
The Dictatorship2 years agoLuigi Mangione acknowledges public support in first official statement since arrest
-
Politics2 years agoBlue Light News’s Editorial Director Ryan Hutchins speaks at Blue Light News’s 2025 Governors Summit